진행성 위암에서 수술전 화학 요법이 병기 저하에 미치는 효과

라기혁; 김용일; 노성훈; 김명진; 김호근; 민진식

YUHSpace

BROWSE

0 245

Cited 0 times in

진행성 위암에서 수술전 화학 요법이 병기 저하에 미치는 효과

DC Field	Value	Language
dc.contributor.author	김호근	-
dc.contributor.author	노성훈	-
dc.date.accessioned	2021-12-27T16:49:52Z	-
dc.date.available	2021-12-27T16:49:52Z	-
dc.date.issued	1995-12	-
dc.identifier.issn	1226-0053	-
dc.identifier.uri	https://ir.ymlib.yonsei.ac.kr/handle/22282913/186177	-
dc.description.statementOfResponsibility	prohibition	-
dc.publisher	대한외과학회	-
dc.relation.isPartOf	JOURNAL OF THE KOREAN SURGICAL SOCIETY (대한외과학회지)	-
dc.rights	CC BY-NC-ND 2.0 KR	-
dc.title	진행성 위암에서 수술전 화학 요법이 병기 저하에 미치는 효과	-
dc.title.alternative	The Clinicopathological Down Staging Effect of Neoadjuvant Chemotherapy in Far Advanced Gastric Cancer	-
dc.type	Article	-
dc.contributor.college	College of Medicine (의과대학)	-
dc.contributor.department	Dept. of Pathology (병리학교실)	-
dc.contributor.googleauthor	라기혁	-
dc.contributor.googleauthor	김용일	-
dc.contributor.googleauthor	노성훈	-
dc.contributor.googleauthor	김명진	-
dc.contributor.googleauthor	김호근	-
dc.contributor.googleauthor	민진식	-
dc.contributor.localId	A01183	-
dc.contributor.localId	A01281	-
dc.relation.journalcode	J01893	-
dc.subject.keyword	Significant portion of gastric cancer patients are non-resectable at the time of diagnosis or exploration. Despite the introduction of variety of multidiciplinary therapy. The prognosis of these patients is nor and beyond hope of cure. There are some reports that neoadjuvant chemotherapy may improve the resectability. So we tried to investigate the clinicopathological effect of neoadjuvant chemotherapy in far advanced gastric cancer and to assess the surgical outcome after neoadjuvant chemotherapy. The present report is concerned wit 27 patients who were initially diagnosed with locally advanced or non-resectable gastric cancer and later assessed as resectable after neoadjuvant chemotherapy. The clinical staging was done according to the AjCC staging.. The neoadjuvant chemotherapy consisted of a 5-FU based regimen injected an average of 3.7 cycle. The median age of the patients studied was 53 year old with 16: 11 male to female ratio. In the preoperative study, pancreas was the most commonly involved adjacent organ with 19 cases and 3 cases and 3 cases showed involvement in two or more adjacent organs. Two patients were in stage Ⅲa:9 inⅢb:16 in Ⅳ. In radiologic follow up studies, neoadjuvant chemotherapy showed positive effect in 19 cases(70.4%)[CR:1, PR: 18] and down staging was observed in 11 cases(40.7%). Eight patients showed no response to chem otherapy and 5 cases were up-staged at the time of surgery compared to the initial state. Curative resections were done on 13 cases and palliative resections on 12 cases and nonresection on 2 cases only. This means 92.6% of resectability. After the operation, the pathologic staging according to the AJCC showed 2 cases in stage II: 7 cases in Ⅲa:4 cases in Ⅲb: 14 cases in Ⅳ. Sixteen(59%) of these patients expired within 2 years after surgery and their mean survival time was 24.9 months. Neoadjuvant chemotherapy has made far advanced gastric cancer resectable through its effects of lowering the clinical stage. A more fine and accurate preoperative staging seems to be necessary for more accurate assessment of neoadjuvant chemotherapy.	-
dc.contributor.alternativeName	Kim, Hogeun	-
dc.contributor.affiliatedAuthor	김호근	-
dc.contributor.affiliatedAuthor	노성훈	-
dc.citation.volume	49	-
dc.citation.number	6	-
dc.citation.startPage	922	-
dc.citation.endPage	930	-
dc.identifier.bibliographicCitation	Journal of the Korean Surgical Society (대한외과학회지), Vol.49(6) : 922-930, 1995-12	-

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

Show simple item record Find it @ YMLIB

License

YUHSpace: 진행성 위암에서 수술전 화학 요법이 병기 저하에 미치는 효과

YUHSpace

BROWSE

Browse

Links